Recently, Pfizer has released a statement clarifying the the prices cited for American vaccines in India.
A Pfizer Spokesperson said, “We note certain press reports citing a price for American vaccines in India. As far as Pfizer is concerned, this information is entirely incorrect. During the current pandemic situation worldwide, Pfizer has maintained that its priority would be to exclusively support Governments through supply of its vaccine only to Governments for their immunization programs. This would be our approach in India as well. Further, in all our agreements Pfizer has adopted a distinct pricing structure for high, middle, and low/lower-middle-income countries consistent with our commitment to work towards equitable and affordable access for our COVID-19 vaccine for people around the world. For India, Pfizer has offered a not-for-profit price for its vaccine for the Government immunization program. We continue to be in discussions with the Government and remain committed to make our vaccine available for deployment in India’s immunization program.”
